cancer

FDA Demands Zantac Heartburn Drug And Generics Pulled Over Carcinogen Fears

FDA Demands Zantac Heartburn Drug And Generics Pulled Over Carcinogen Fears

The U.S. Food and Drug Administration is taking a drastic step over a common drug used to treat allergies and acid reflux, following an investigation that confirmed the persistent presence of a likely carcinogen in products containing it. On Wednesday, the agency announced that it’s requesting all manufacturers of ranitidine…